跳到主要內容

很遺憾,我們無法支援你的瀏覽器。如果可以,請升級到新版本,或使用 Mozilla Firefox、Microsoft Edge、Google Chrome 或 Safari 14 或更新版本。如果無法升級,而且需要支援,請將你的回饋寄給我們。

我們衷心感謝你對這個新體驗的回饋。告訴我們你的想法

Elsevier
與我們共同出版

Committee & Speakers

Conference Chairs

Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany

Fen-Biao Gao, University of Massachusetts Chan Medical School, USA

Aaron Gitler, University of Stanford, USA

Speakers

Keynote

Victor Ambros

Victor Ambros

University of Massachusetts Chan Medical School, USA

繼續閱讀 Victor Ambros

Session 1: Dysregulated RNA metabolism in neurological diseases

PF

Pietro Fratta

University of College London, UK

LT

Leslie Thompson

University of California, Irvine, USA

Session 2: Physiological functions of disease-linked RNA-binding proteins

JR

Joel Richter

University of Massachusetts Chan Medical School, USA

Gene Yeo

Gene Yeo

University of California, San Diego, USA

繼續閱讀 Gene Yeo

Session 3: Biomolecular condensates and their role in normal RNA processing and in disease

Simon Alberti

Simon Alberti

Dresden University of Technology, Germany

繼續閱讀 Simon Alberti
Roy Parker

Roy Parker

University of Colorado, Boulder, USA

繼續閱讀 Roy Parker

Session 4: Human genetics and genomics insights into neurological diseases

DC

Don Cleveland

University of California, San Diego, USA

Rosa Rademakers

Rosa Rademakers

VIB Center for Molecular Neurology, Antwerp, Belgium

繼續閱讀 Rosa Rademakers

Session 5: Structural insights into pathological RNA-binding proteins

MP

Magdalini Polymenidou

University of Zürich, Switzerland

Ben Ryskeldi-Falcon

Ben Ryskeldi-Falcon

MRC Cambridge, UK

繼續閱讀 Ben Ryskeldi-Falcon

Session 6: Toxicity of repeat RNAs and repeat proteins

DE

Dieter Edbauer

German Center for Neurodegenerative Diseases, Munich, Germany

LR

Laura Ranum

University of Florida, Gainesville, USA

Session 7: Novel biomarkers due to dysregulated RNA metabolism

MW

Michael Ward

National Institutes of Health, USA

Philip Wong

Philip Wong

Johns Hopkins University, USA

繼續閱讀 Philip Wong

Session 8: RNA-based therapeutics

AK

Anastasia Khvorova

University of Massachusetts Chan Medical School, USA

MS

Matthew Simon

Denali Therapeutics, USA

Discussion leaders

Session 1: Benjamin Wolozin, Boston University, USA Session 2: Albert La Spada, University of California Irvine, USA Session 3: Yi Lin, Tsinghua University, Beijing, China Session 4: Nancy Bonini, University of Pennsylvania, USA Session 5: Lin Guo, Thomas Jefferson University, USA Session 6: Jeffrey Rothstein, Johns Hopkins University, USA Session 7: Leonard Petrucelli, Mayo Clinic, USA Session 8: Dorothee Dormann, Johannes Gutenberg University, Mainz, Germany